High levels of CD8
tumor
TUMOR
We asked whether levels of T cells in tumor specimens pre-treatment were associated with progression-free survival (PFS). The percentage of cells staining positive for CD8 ranged from 0.01% to 10.3% (median 0.22%), while the percentage of CD3